Getting the one-dose RSV vaccine is one of the easiest ways to do so. Over the last two years, Oklahoma City has seen an ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

The NHS is urging eligible patients to protect themselves this winter by getting vaccinated against respiratory syncytial ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

As cold and flu season ramps up, the most vulnerable among us need extra protection. Infants are among the most susceptible ...